Evidence map›Paper›PMID 36077332›Full record

ReviewInternational journal of molecular sciences2022

Microbial Lipases and Their Potential in the Production of Pharmaceutical Building Blocks.

César A Godoy, Juan S Pardo-Tamayo, Oveimar Barbosa

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Synthesis and characterization of ZrFeNanoscale advances · 2026
    Article
  4. Functional potential of gut microbiota inFrontiers in microbiology · 2026
    Article
  5. Chemical Modification ofInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Recent insight into the advances and prospects of microbial lipases and their potential applications in industry.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Engineering aRSC advances · 2023
    Article
  18. Article
  19. Biocatalysis: An Eco-Friendly Scenario for the Manufacturing of APIs.International journal of molecular sciences · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

César A GodoyLaboratorio de Investigación en Biocatálisis y Biotransformaciones (LIBB), Grupo de Investigación en Ingeniería de los Procesos Agroalimentarios y Biotecnológicos (GIPAB), Departamento de Química, Universidad del Valle, Cali 76001, Colombia.ORCID 0000-0003-4393-9889
Juan S Pardo-TamayoLaboratorio de Investigación en Biocatálisis y Biotransformaciones (LIBB), Grupo de Investigación en Ingeniería de los Procesos Agroalimentarios y Biotecnológicos (GIPAB), Departamento de Química, Universidad del Valle, Cali 76001, Colombia.ORCID 0000-0002-0345-2489
Oveimar BarbosaGrupo de Investigación de Materiales Porosos (GIMPOAT), Departamento de Química, Universidad del Tolima, Ibague 730001, Colombia.ORCID 0000-0001-9479-8807
Universidad del Valle · COUniversity of Tolima · CO

Funding

Colciencias Grant 745-2016-Project 110671250425University of Tolima N° 005-2021-Project code N°: 660121University of Valle CI 71314
6 · The paper itself

Abstract

Processes involving lipases in obtaining active pharmaceutical ingredients (APIs) are crucial to increase the sustainability of the industry. Despite their lower production cost, microbial lipases are striking for their versatile catalyzing reactions beyond their physiological role. In the context of taking advantage of microbial lipases in reactions for the synthesis of API building blocks, this review focuses on: (i) the structural origins of the catalytic properties of microbial lipases, including the results of techniques such as single particle monitoring (SPT) and the description of its selectivity beyond the Kazlauskas rule as the "Mirror-Image Packing" or the "Key Region(s) rule influencing enantioselectivity" (KRIE); (ii) immobilization methods given the conferred operative advantages in industrial applications and their modulating capacity of lipase properties; and (iii) a comprehensive description of microbial lipases use as a conventional or promiscuous catalyst in key reactions in the organic synthesis (Knoevenagel condensation, Morita-Baylis-Hillman (MBH) reactions, Markovnikov additions, Baeyer-Villiger oxidation, racemization, among others). Finally, this review will also focus on a research perspective necessary to increase microbial lipases application development towards a greener industry.

Indexed as

IndustryLipaseCatalysisChemistry Techniques, SyntheticPharmaceutical PreparationsLipasePharmaceutical PreparationsActive Pharmaceutical Ingredients (APIs)building blockslipase catalytic propertieslipase immobilizationmicrobial lipasepromiscuity

Identifiers

PMID36077332
PMCPMC9456414
OpenAlexW4294253121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.